Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Philippe Gevaert, Theodore A. Omachi, Jonathan Corren, Joaquim Mullol, Joseph K. Han, Stella E. Lee, Derrick Kaufman, Monica Ligueros‐Saylan, Monet Howard, Rui Zhu, Ryan Owen, Kit Wong, Lutaf Islam, Claus Bachert
Topics & Concepts
Nasal polypsMedicineOmalizumabNasal congestionPlaceboNoseInternal medicineAsthmaNasal administrationEosinophilic esophagitisGastroenterologyAdverse effectImmunoglobulin ESurgeryImmunologyPathologyAntibodyDiseaseAlternative medicineSinusitis and nasal conditionsAllergic Rhinitis and SensitizationDrug-Induced Adverse Reactions